The effect of mycophenolate mofetil on primary and secondary treatment of primary glomerulonephritis and lupus nephritis


PAYDAŞ S., KURT C., TAŞKAPAN H. , BALAL M., SERTDEMİR Y., Pembegul I.

INTERNATIONAL UROLOGY AND NEPHROLOGY, cilt.41, ss.145-152, 2009 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 41 Konu: 1
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1007/s11255-008-9454-4
  • Dergi Adı: INTERNATIONAL UROLOGY AND NEPHROLOGY
  • Sayfa Sayıları: ss.145-152

Özet

Mycophenolate mofetil (MMF) has shown to be a reliable choice in the treatment of glomerulonephritis. We retrospectively reviewed the clinical course and response to MMF therapy in 49 patients with primary glomerulopathy (37 patients) and lupus nephritis [class III (five patients) and IV (seven patients)].